C07C 217/34
By halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound
Official title: by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
C07C217/34 (By halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound) appears on 51 US grants and 59 published applications in this corpus.
Search patents in C07C- Granted patents
- 51
- Published applications
- 59
- Assignees
- 47
- Inventors
- 234
- Latest grant
- 30 Sep 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 2 | 0 |
| 1992 | 0 | 0 |
| 1993 | 2 | 0 |
| 1994 | 0 | 0 |
| 1995 | 2 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 2 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 1 |
| 2002 | 2 | 5 |
| 2003 | 4 | 3 |
| 2004 | 2 | 5 |
| 2005 | 1 | 4 |
| 2006 | 4 | 6 |
| 2007 | 3 | 0 |
| 2008 | 2 | 1 |
| 2009 | 2 | 5 |
| 2010 | 2 | 1 |
| 2011 | 0 | 3 |
| 2012 | 0 | 0 |
| 2013 | 2 | 2 |
| 2014 | 0 | 2 |
| 2015 | 1 | 4 |
| 2016 | 3 | 3 |
| 2017 | 0 | 0 |
| 2018 | 2 | 2 |
| 2019 | 0 | 1 |
| 2020 | 1 | 1 |
| 2021 | 1 | 3 |
| 2022 | 0 | 2 |
| 2023 | 1 | 0 |
| 2024 | 3 | 2 |
| 2025 | 1 | 2 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- P62 ligand compound, and composition for preventing, ameliorating or treating proteinopathies comprising the same30 Sep 2025US 12,427,346 B2Autotac Inc.
- AUTOTAC chimeric compound, and composition for preventing, ameliorating or treating diseases through targeted protein degradation comprising the same29 Oct 2024US 12,129,218 B2Autotac Inc.
- Store overload-induced calcium release inhibitors and methods for producing and using the same17 Sep 2024US 12,091,408 B2UTI Limited Partnership
- P62 ligand compound, and composition for preventing, ameliorating or treating proteinopathies comprising the same14 May 2024US 11,981,618 B2Autotac Inc.
- Small molecule AMPK activators13 Jun 2023US 11,673,853 B2The United States AS Represented By the Department of Veterans Affairs
- Methods for producing viloxazine salts and novel polymorphs thereof8 Jan 2026US 2026/0008759 A1Supernus Pharmaceuticals, Inc.
- Salt of a pharmaceutical compound17 Jul 2025US 2025/0228799 A1Actimed Therapeutics Limited
- Antibacterial composition17 Apr 2025US 2025/0120944 A1Seoul National University R&Db Foundation
- Bacterial efflux pump inhibitors and methods of use24 Oct 2024US 2024/0350454 A1
- Broad spectrum antiviral compounds targeting the ski complex25 Apr 2024US 2024/0132484 A1University of Maryland, Baltimore
Most cited
By later US patents
- 2-amino-1,3-propanediol compound and immunosuppressant76US 5,604,229 ATaito Co., Ltd. · 1997
- Aryloxypropanolaminotetralins, a process for their preparation and pharmaceutical compositions containing them34US 5,254,595 AElf Sanofi · 1993
- β2-adrenergic receptor agonists23US 6,713,651 B1Theravance, Inc. · 2004
- 2-amino-1,3-propanediol compound and immunosuppressant18US 5,719,176 ATaito Co., Ltd. · 1998
- Chemical compounds15US 4,999,377 AImperial Chemical Industries PLC · 1991